G2 Investment Partners Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
BG
G2 Investment Partners Management's CDNA Position: Q2 2022 in Review
G2 Investment Partners Management sold out of CareDx (CDNA) in Q2 2022, closing a stake of 94,779 shares — an estimated $3.51M sold.
G2 Investment Partners Management first reported a position in CDNA in Q4 2017 and held it in 16 quarters. The position peaked at $14.3M in Q4 2020. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.
- G2 Investment Partners Management reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
- G2 Investment Partners Management sold 94,779 CareDx shares in Q2 2022, an estimated $3.51M.
- G2 Investment Partners Management first reported a position in CareDx in Q4 2017 and held it in 16 quarters.
- G2 Investment Partners Management's CareDx position peaked at $14.3M in Q4 2020.
- 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.
Based on G2 Investment Partners Management's 13F filing for Q2 2022, filed 15 Aug 2022.